By
Jeff Dale2023-10-12T18:26:00
Former Barclays Chief Executive Jes Staley was fined 1.8 million pounds (U.S. $2.2 million) and banned from serving in a senior management role in the financial services industry by the U.K. Financial Conduct Authority (FCA) for allegedly misleading the regulator regarding his ties to disgraced financier Jeffrey Epstein.
Staley “recklessly” approved a letter from Barclays to the FCA that lied about the nature of his relationship with Epstein and when their last contact occurred, the regulator said Thursday in a press release.
Staley appealed the FCA’s decision to a tribunal.
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
2023-11-03T13:00:00Z By Neil Hodge
The U.K. Financial Conduct Authority’s decision to ban Jes Staley, the former CEO of Barclays, for misrepresenting his relationship with Jeffrey Epstein has seemingly reaffirmed the notion that everyone—even the boss—is accountable for their actions.
2023-09-26T16:59:00Z By Kyle Brasseur
JPMorgan Chase agreed to pay $75 million as part of a settlement with the government of the U.S. Virgin Islands regarding the bank’s ties to convicted sex offender Jeffrey Epstein.
2023-06-12T16:38:00Z By Kyle Brasseur
JPMorgan Chase announced it reached an agreement in principle to settle claims made in a class-action lawsuit regarding the bank’s ties to convicted sex offender Jeffrey Epstein.
2026-02-05T00:55:00Z By Ruth Prickett
Major accountancy firms in France are under investigation for anti-competitive practices. The French competition watchdog embarked on a series of “unannounced inspections” and removed documents relating to audit and reporting on Jan. 13.
2026-02-03T23:22:00Z By Neil Hodge
The European Commission has launched a formal investigation against Elon Musk’s X under the Digital Services Act over fears that its AI tool Grok may be producing and disseminating illegal material.
2026-02-03T22:57:00Z By Adrianne Appel
Three former executives at Archer-Daniels-Midland intentionally misled investors by inflating the performance of the company’s Nutrition unit, the U.S. Securities and Exchange Commission has alleged.
Site powered by Webvision Cloud